Eam Investors, LLC Verastem, Inc. Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $937,260 - $1.5 Million	-369,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $948,329 - $1.79 Million	369,000 New	369,000 $1.5 Million
Q2 2020 Aug 13, 2020	SELL	$1.69 - $4.2 $368,012 - $914,587	-217,759 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.26 - $3.38 $274,376 - $736,025	217,759 New	217,759 $575,000
Q3 2018 Nov 08, 2018	SELL	$6.86 - $9.97 $3.28 Million - $4.76 Million	-477,869 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$2.88 - $8.67 $1.38 Million - $4.14 Million	477,869 New	477,869 $3.29 Million
Q4 2017 Feb 12, 2018	SELL	$2.99 - $4.85 $1.33 Million - $2.16 Million	-445,017 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$3.01 - $5.41 $1.34 Million - $2.41 Million	445,017	445,017 $2.09 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.